Compounds > dexmedetomidine
Page last updated: 2024-08-24

dexmedetomidine and Neuroblastoma

dexmedetomidine has been researched along with Neuroblastoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (45.45)24.3611
2020's6 (54.55)2.80

Authors

AuthorsStudies
Jiang, Z; Liu, A; Peng, Y; She, C; Xu, Y; Zhu, J1
Shao, G1
Chen, L; Li, X; Luo, X; Shen, S; Wang, J; Xu, W1
Chen, J; Chen, P; Chen, X; Chen, Y; Gao, F; Gong, C; Lin, M; Qian, H; Zhang, H; Zheng, T; Zheng, X1
Liu, L; Sun, Y; Tan, Q; Wang, Q; Wang, S1
Guo, Y; Li, N; Wang, Z; Wu, Y1
Cheung, W; Deyell, R; Görges, M; Lauder, G; West, N; Winton, P1
DuBois, SG; Gustafson, C; Hawkins, R; Lee, JS; Matthay, K; Roy-Burman, A; Wong, T; Wu, R1
Batra, V; Elias, J; Makvandi, M; Maris, JM; Patel, N; Pryma, DA; Zuppa, AF1
Davis, J; Reimer, EJ; Whyte, E; Whyte, S; Winton, P1
Hamabata, T; Hata, D; Mizumoto, H; Oda, Y; Shiota, M; Taniguchi, M1

Other Studies

11 other study(ies) available for dexmedetomidine and Neuroblastoma

ArticleYear
Dexmedetomidine Inhibits NF-κB-Transcriptional Activity in Neurons Undergoing Ischemia-Reperfusion by Regulating O-GlcNAcylation of SNW1.
    Journal of neuropathology and experimental neurology, 2022, 09-19, Volume: 81, Issue:10

    Topics: Animals; Dexmedetomidine; Humans; Ischemia; Neuroblastoma; Neurons; NF-kappa B; Nuclear Receptor Coactivators; Rats; Reperfusion

2022
Dexmedetomidine inhibits cerebral nerve cell apoptosis after cerebral hemorrhage in rats via the Nrf2/HO-1/NQO1 signaling pathway.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:13

    Topics: Animals; Apoptosis; Cerebral Hemorrhage; Dexmedetomidine; Heme Oxygenase-1; Humans; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Rats; Signal Transduction; Superoxide Dismutase; Water

2022
Dexmedetomidine pretreatment alleviates ropivacaine-induced neurotoxicity via the miR-10b-5p/BDNF axis.
    BMC anesthesiology, 2022, 09-26, Volume: 22, Issue:1

    Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Dexmedetomidine; Humans; Lactate Dehydrogenases; Mice; MicroRNAs; Neuroblastoma; Neuroprotective Agents; Ropivacaine

2022
Dexmedetomidine Regulates Autophagy via the AMPK/mTOR Pathway to Improve SH-SY5Y-APP Cell Damage Induced by High Glucose.
    Neuromolecular medicine, 2023, Volume: 25, Issue:3

    Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Cell Line, Tumor; Dexmedetomidine; Glucose; Humans; Neuroblastoma; TOR Serine-Threonine Kinases

2023
Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD : The Role of Dexmedetomidine in AD.
    Neurotoxicity research, 2023, Volume: 41, Issue:5

    Topics: Alzheimer Disease; Apoptosis; Dexmedetomidine; Heat-Shock Proteins; Humans; Molecular Chaperones; Neuroblastoma; Neurons; RNA Helicases; RNA, Long Noncoding; Trans-Activators

2023
Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53.
    Experimental and molecular pathology, 2021, Volume: 118

    Topics: Adrenergic alpha-2 Receptor Agonists; Amyloid beta-Peptides; Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Death-Associated Protein Kinases; Dexmedetomidine; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neuroblastoma; Neuroprotective Agents; PC12 Cells; Rats; Reactive Oxygen Species; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2021
Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:1

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Antibodies, Monoclonal; Child; Child, Preschool; Dexmedetomidine; Drug Therapy, Combination; Female; Follow-Up Studies; Gangliosides; Humans; Hydromorphone; Immunotherapy; Male; Neuroblastoma; Pain; Pain Management; Prognosis

2015
Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:3

    Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Conscious Sedation; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Infant; Infusions, Intravenous; Male; Neuroblastoma; Pyridazines; Radiopharmaceuticals

2016
Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:4

    Topics: 3-Iodobenzylguanidine; Dexmedetomidine; Humans; Hypnotics and Sedatives; Iodine Radioisotopes; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured

2017
Dexmedetomidine for co-analgesia in chemotherapy-induced severe enterocolitis.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:9

    Topics: Adrenal Gland Neoplasms; Analgesics, Non-Narcotic; Analgesics, Opioid; Antineoplastic Agents; Child, Preschool; Dexmedetomidine; Enterocolitis; Female; Humans; Hydromorphone; Infusions, Intravenous; Neuroblastoma; Pain; Pain Measurement

2011
Dexmedetomidine infusion for sedation in the intensive care setting in an infant with airway compromise due to congenital mediastinal neuroblastoma.
    Paediatric anaesthesia, 2012, Volume: 22, Issue:6

    Topics: Airway Management; Airway Obstruction; Analgesics, Opioid; Antineoplastic Agents; Carboplatin; Critical Care; Dexmedetomidine; Female; Fentanyl; Humans; Hypnotics and Sedatives; Infant, Newborn; Infusions, Intravenous; Mediastinal Neoplasms; Midazolam; Neuroblastoma

2012